Академический Документы
Профессиональный Документы
Культура Документы
I.
-
Reaction Kinetics
Rate equations to describe
progress of first-order and
second-order reactions
Michaelis-Menten eqn: Vi Vmax,
Km
Overall catalytic efficiency =
kcat/Km
Lineweaver-Burk plot: present
data and calculate Km, Vmax
Bisubstrate Reactions can be
Ordered/Random/Pingpong
mechanism
independent of substrate
concentration (zeroth order)
- k2 becomes rate-limiting step
M-M Equation assumes ES as steady
state
- k-1 >> k1
- Since [S]>>[E], [ES] assumed to
be
constant until [S] depleted
(steady state)
2. Random Mechanism
- no order of preference for
substrate
addition
Ordered Mechanism
II.
-
to
form binding site for 2nd substrate
Enzyme Inhibition
Inhibitors interact
reversibly/irreversibly to change
Km and/or Vmax
Competitive IN: binds with
active site,
Km
Uncompetitive IN: Km Vmax
Mixed enzyme inhibitor: Vmax,
/Km
Inhibitors
- substances that reduce
enzymes
activity: a) Irreversible - tightly
binds with
enzyme and permanently block
activity
Competitive Inhibition
- directly competes with normal
substrate
at the active site
e.g. malonate inhibits succinate
dehydrogenase
Product inhibition
- products formed may bind at
the
active site, accumulate and
compete
with substrate
- control in cell activity
Transition state analogs
- effective catalysis dependent
on
enzymes ability to bind and
stabilize TS
- compound mimics TS
catalytic
nature of the enzyme and not
formation of ES
complex
than it is
- however, at [S], vo Vmax
*Principle behind use of ethanol for
methanol poisoning. Ethanol competes
at active site, versus methanol
slowing production of formaldehyde
methanol excreted through urine
Uncompetitive Inhibition
Inhibitor binds directly to ES complex
but not
to free enzyme
- distorts the active site
inactivated enzyme
- addition of substrate wont affect
the effect
- substrate binding doesnt affect
binding of inhibitor
- require that inhibitor affect the
Irreversible Inhibitor
- resemble pure noncompetitive
inhibitor =
cooperatively
Ways to control:
1.
Enzyme Availability
Enzyme Activity
- modulation of activity by
structural
alteration that influence ES
complex
formation or turnover number
- allosteric effectors that cause
changes
in enzymatic activity
- covalent modification, usually
phodephosphorylation of specific Ser,
Thr, Tyr
residues
Allosteric Control by binding at
site not the active site
e.g. aspartate carbamoylase
(ATCase)
- catalyzes N-carbamoyl
aspartate
carbamoyl phosphate +
aspartate
- both substrate bind
- allosterically inhibited by
cytidine
triphosphate (CTP), pyrimidine
nucleotide
- allosterically activated by
adenosine
triphosphate (ATP), purine
nucleotide
- CTP, a feedback inhibitor,
inhibits its
earlier step in its biosynthesis
- [CTP], CTP synthesis
- [CTP], CTP dissociates from
ATCase
CTP synthesis
- coordination of ATP and CTP in
purine
and pyrimidine synthesis
- [ATP]>[CTP] ATCase
activated to
form pyrimidine nucleotides until
equal
- [CTP]>[ATP] permits ATP
synthesis
phosphorylated form
+
phosphoryl group
esterified to Ser 14
- glucose as only allosteric
effector
- binds to T-state inactivating
enzyme
phosphorylase b (pb) =
dephosphorylated form
- ATP, glucose-6-phosphate
(G6P, upon
conversion of G1P) prefers
binding with T
state of pb inactivating enzyme
- AMP prefers binding with R state
of pa
activating enzyme
muscle excertion; ATP, G6P,
glucose
concentration (thus no need for
glycogen
breakdown)
muscle excertion; AMP (induce
breakdown to help fuel metabolism)
In phosphorylase a,
terminal
region glycogen phosphorylases
helices
pull apart triggers quaternary T to
R
transition
* Ser 14 acts as internal allosteric
effector to
shift T R equilibrium toward R
state
Cascades of Protein Kinases = Greater
sensitivity
- protein kinases/phosphatases
linked in
series
- greater capacity at signal
amplification
because small fractional change in
effector
concentration cause larger fractional
enzymatic activity